Antenatal antipsychotic exposure induces multigenerational and gender-specific programming of adiposity and glucose tolerance in adult mouse offspring

作者：Courty E; Gobalakichenane P; Garcia M; Muscat A; Kazakian C; Ledent T; Moldes M; Blondeau B; Mitanchez D; Buyse M; Feve B^*

来源：Diabetes & Metabolism, 2018, 44(3): 281-291.

DOI：10.1016/j.diabet.2017.06.005

• Antipsychotics
• Drug antenatal exposure
• Energy homoeostasis
• Olanzapine
• Sexual dimorphism
• Transgenerational

Second-generation antipsychotics (SGAs) are well known for their metabolic side effects in humans, including obesity and diabetes. These compounds are maintained during pregnancy to prevent the relapse of psychoses, but they readily diffuse across the placenta to the fetus, as documented with the widely-prescribed drug olanzapine (OLZ). However, observational studies have provided conflicting results on the potential impact of SGAs on fetal growth and body weight, and their effects on metabolic regulation in the offspring. For this reason, our study has tested whether antenatal exposure of CD1 mice to OLZ influenced metabolic outcomes in the offspring of the first (F1) and second (F2) generations. In Fl mice, OLZ antenatal treatment caused a decrease in neonatal body weight in both genders, an effect that persisted throughout life only in male animals. Interestingly, Fl female mice also displayed altered glucose homoeostasis. F2 mice, generated by mating normal males with Fl female mice exposed to OLZ during antenatal life, exhibited higher neonatal body weights which persisted only in F2 female animals. This was associated with expansion of fat mass and a concordant pattern of adipose tissue gene expression. Moreover, male and female F2 mice were glucose-intolerant. Thus, our study has demonstrated that antenatal OLZ exposure induces multigenerational and gender-specific programming of glucose tolerance in the offspring mice as adults, and points to the need for careful monitoring of children exposed to SGAs during pregnancy.

• 出版日期2018-6